ArticleChinese medical journal2025

Neoadjuvant therapy with immune checkpoint inhibitors in combination with chemotherapy vs . chemotherapy alone in HER2(-) locally advanced gastric cancer: A propensity score-matched cohort study.

Gehan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.